In a discussion with Oprah, Dr Ania called obesity a disease. She also advised that we should treat obesity like other ...

GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...

Developed initially to manage diabetes, glucagon-like peptide-1 (GLP-1) receptor agonists have skyrocketed in popularity ...

Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...

( MENAFN - Swissinfo) Swiss medicines regulator Swissmedic has taken legal action against media houses in Switzerland for ...

After stopping Ozempic, many struggle to maintain weight loss due to hormonal changes, behavioral factors, and a slowed ...

Weight loss drugs like Ozempic and Wegovy have been tied in a large, national study to a drop in the risk of developing dozens of health conditions. But the semaglutide-like drugs also appear to ...

Ozempic has made headlines as a go-to medication for managing diabetes and aiding weight loss, but its popularity comes with ...

A study has suggested that the use of weight-loss jabs may be associated with wider health benefits, including a lower risk ...